NRX Pharmaceuticals Inc
Filed Nov 14, 2024.
View on SEC.govAbout this filing
A company's registration of shares for sale to the public, often for a first offering. It describes the business, its risks and how the company plans to use the money.
period unavailable · Filed Nov 14, 2024
Contents
EXPERTS
The consolidated financial statements of NRx Pharmaceuticals, Inc. as of December 31, 2023, and for the year then ended, have been incorporated by reference herein in reliance upon the report of Salberg & Company, P.A., independent registered public accounting firm, and upon the authority of such firm as experts in accounting and auditing. The consolidated financial statements of NRx Pharmaceuticals, Inc. as of December 31, 2022, and for the year then ended, have been incorporated by reference herein in reliance upon the report of KPMG LLP, independent registered public accounting firm, and upon the authority of such firm as experts in accounting and auditing.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.